Cell Culture-Based Viral Vaccines – Efficient Cell Disruption with Sonication

Frequently Asked Questions about Ultrasonic Cell Disruption for Viral-Based Vaccine Production

What is ultrasonic cell disruption?

Ultrasonic cell disruption uses high-intensity ultrasound, typically in the range of 20 to 30 kHz, to break open cell membranes and release intracellular material. High-power ultrasound waves create cavitation bubbles in the liquid. When these bubbles collapse, they generate intense local shear forces and microstreaming which mechanically disrupt the cells and promote mass transfer between the cell interior and the surrounding medium. In vaccine production, this is used to lyse virus-infected cell cultures and to release intracellular and membrane-associated virus particles into the harvest.

Why use sonication instead of chemical or enzymatic lysis for viral harvest?

Sonication works with purely mechanical forces. No detergents, lysozyme, proteinase K or other lysis reagents are required which might alter the lysate, interfere with downstream purification or need to be removed before further processing. Chemical reagents typically require time-consuming multi-step preparation to prevent inhibition of subsequent assays and other post-processing steps. Enzymatic disruption requires long incubation times and often delivers non-reproducible results. Ultrasonic lysis also overlaps the steps of resuspension, disruption and extraction into a single continuous operation. Where a detergent- or enzyme-assisted step is required by your process, sonication intensifies it rather than replacing it: cavitation weakens membranes and improves uniform exposure of all cells to the reagent.

How does sonication compare to mechanical homogenization methods?

Probe-type sonicators transfer ultrasonic energy directly and efficiently, because the sonotrode is in direct contact with the sample. Mechanically driven homogenization techniques often result in lower energy transfer efficiency. Ultrasonic processing needs no consumable grinding beads or rotating seals in the product stream, no nozzles or chambers that can clog with viscous cell mass, and no cross-contamination between batches.

Can sonication damage the virus or the antigen?

This is the key optimization task, and it is controllable. By adjusting the parameters of ultrasonic processing, the effects of sonication can be precisely controlled: low amplitude and short sonication have very soft effects, while high amplitudes, elevated pressure and longer sonication duration result in intense processing. Since the intensity can be adjusted exactly to the biological sample, over-processing, degradation and yield loss are avoided. In practice, amplitude, residence time and number of passes are set to the minimum that achieves the target disruption rate, with continuous temperature monitoring and cooling.

Does ultrasonic treatment reduce the viscosity of the harvest?

Yes. Dense, high cell-density harvests are viscous and difficult to pump because of released, unfragmented host-cell DNA. Ultrasonic treatment shears and fragments DNA and RNA, and it solubilizes the cell mass and deagglomerates cell debris. The result is a homogeneous, pumpable suspension that feeds clarification, centrifugation and chromatography more efficiently. DNA and RNA fragmentation by controlled sonication is a well-established laboratory application of the same technology.

Can I run the process in continuous inline mode?

Yes. Hielscher sonicators are designed for 24/7 continuous operation in industrial environments and can be configured with flow cells and reactors for continuous inline sonication, recirculation loops or integration into production skids and processing lines. Single-pass and multi-pass operation are both possible.

How do I scale up from the lab to production?

Linearly, based on measurable energy input. All sonication results obtained with a Hielscher ultrasonic homogenizer can be scaled up linearly to higher throughputs in industrial manufacturing; sonication parameters developed with a bench-top sonicator can be transferred directly to larger Hielscher systems. The scale-up criterion is the specific energy input per volume, together with amplitude, residence time and temperature. Hielscher process consulting includes recommendations for parameter optimization (amplitude, specific energy E/V, residence time, temperature and pressure control) tied to measurable energy input.

Is ultrasonic cell disruption suitable for cleanroom and GMP-style manufacturing?

Hielscher ultrasonicators can be easily installed in cleanroom laboratories and production facilities. The housings are made from antibacterial plastic or stainless steel. All wetted parts, such as sonotrodes and flow cells, are made from titanium or stainless steel and can be autoclaved. Special flow cell reactors meeting advanced CIP (clean-in-place) and SIP (sterilize-in-place) requirements are available. The transducer of the industrial UIP series is IP64 rated and can be installed in demanding environments while the generator is placed remotely. Because Hielscher sonicators convert electrical energy into mechanical oscillation with a very high efficiency of approximately 80–90% from the power plug into the liquid, the transducer can be built into closed housings without louvers, and no forced cooling such as compressed air or water is needed. This also means no cooling medium comes into contact with the process. Automatic process documentation supports traceability and reproducibility in regulated manufacturing.

Can sonication also inactivate the virus for an inactivated vaccine?

Yes. Power ultrasound finds application in the inactivation of pathogens such as bacteria and viruses. With the appropriate dose and intensity of sonication, cells and microbes can be treated in accordance with the process goal, so the same platform serves lysis for harvest and inactivation. The combination of sonication and heat, known as thermo-sonication, offers a faster rate of sterilization with significantly reduced thermal intensity and duration, which is advantageous for preserving heat-sensitive compounds such as proteins and antigens. Ultrasonic inactivation is generally used in combination with established inactivation chemistry, and the full inactivation kinetics must be validated for each specific virus.

Can the same system be used for the formulation steps after harvest?

Yes. The same platform handles antigen dispersion into suspensions, polymers or liposomal encapsulations, the deagglomeration and uniform distribution of antigens and aluminum-based adjuvants such as Alhydrogel™, the formulation of vaccines into liposomes and solid-lipid nanoparticles with precise control over carrier size, and the degassing step prior to filling into vials or syringes.